
Granules India Limited has informed the Exchange regarding a press release dated September 07, 2024, titled "Granules India s Gagillapur Facility Completes US FDA Inspection with Six Observations".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated September 07, 2024, titled "Granules India s Gagillapur Facility Completes US FDA Inspection with Six Observations".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India